Boston Scientific Corp. (NYSE:BSX) shares traded -0.52% lower at $67.44 on Wall Street last session.
BSX stock price is now 4.87% away from the 50-day moving average and 20.76% away from the 200-day moving average. The market capitalization of the company currently stands at $98.94B.
With the price target enhanced from $65 to $80, Mizuho Upgraded its rating from Neutral to Buy for Boston Scientific Corp. (NYSE: BSX). On July 19, 2023, Robert W. Baird recently initiated its ‘Outperform’ rating on the stock quoting a target price of $59, while ‘CL King’ rates the stock as ‘Buy’
In other news, Mirviss Jeffrey B., EVP&Pres, Periph Intervent sold 14,506 shares of the company’s stock on Mar 18 ’24. The stock was sold for $963,930 at an average price of $66.45. Upon completion of the transaction, the EVP&Pres, Periph Intervent now directly owns 58,098 shares in the company, valued at $3.92 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Mar 01 ’24, EVP, Human Resources Carruthers Wendy sold 6,983 shares of the business’s stock. A total of $463,322 was realized by selling the stock at an average price of $66.35. This leaves the insider owning 53,788 shares of the company worth $3.63 million. A total of 0.44% of the company’s stock is owned by insiders.
During the past 12 months, Boston Scientific Corp. has had a low of $47.51 and a high of $68.07. As of last week, the company has a debt-to-equity ratio of 0.49, a current ratio of 1.32, and a quick ratio of 0.82. According to the stock market information, the enterprise value for the company is $107.57B, which is based on a 63.01 price-to-earnings ratio, a 5.13 price-to-earnings-growth ratio, and a beta of 0.78. The fifty day moving average price for BSX is $64.49 and a two-hundred day moving average price translates $55.93 for the stock.
The latest earnings results from Boston Scientific Corp. (NYSE: BSX) was released for Dec, 2023. According to the Medical Devices Company, earnings per share came in at $0.55, beating analysts’ expectations of $0.51 by 0.04. This compares to $0.10 EPS in the same period last year. The net profit margin was 11.03% and return on equity was 8.64% for BSX. The company reported revenue of $3.73 billion for the quarter, compared to $3.24 billion a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 14.9 percent. For the current quarter, analysts expect BSX to generate $3.68B in revenue.
